Skip to main content

IMI statement on the outcome of the referendum of the United Kingdom's membership of the European Union


Brussels, Belgium, 4 July 2016 - Following the result of the United Kingdom’s referendum on its membership of the European Union, the Innovative Medicines Initiative (IMI) refers its stakeholders to the following statement, which was published on the European Commission's Participant Portal on 1 July:

'The Statement of 29 June of the Heads of State or Government of 27 Member States, as well as the Presidents of the European Council and the European Commission, confirms that until the UK leaves the EU, EU law continues to apply to and within the UK, both when it comes to rights and obligations. This includes the eligibility of UK legal entities to participate and receive funding in Horizon 2020 actions.'